PDCD1 and cancer: Moreover, they further showed that Tregs present in the TME exhibited upregulated PD-1 gene expression dependent on SREBP activity and mevalonate metabolism signaling (which led to protein geranylgeranylation), thus identifying a new target for cancer therapy.